SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 11 filers reported holding SINOVAC BIOTECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 13,787 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 13,787 | 0.0% | 0.00% | – |
Q3 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
Q2 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
Q4 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
Q3 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
Q2 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
Q1 2021 | $55,000 | 0.0% | 13,787 | -38.4% | 0.00% | – |
Q4 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
Q3 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
Q2 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
Q1 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
Q4 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
Q3 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
Q2 2019 | $55,000 | -61.8% | 22,374 | 0.0% | 0.00% | – |
Q1 2019 | $144,000 | -7.1% | 22,374 | 0.0% | 0.00% | – |
Q4 2018 | $155,000 | -8.8% | 22,374 | 0.0% | 0.00% | – |
Q3 2018 | $170,000 | – | 22,374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |